Warfarin monitoring in nursing homes assessed by case histories. Do recommendations and electronic alerts affect judgements?

References

• Holbrook A, Schulman S, Witt DM, et al. Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e152S–e184S.
   PubMed Web of Science ®Google Scholar
• Kristoffersen AH, Thue G, Ajzner E, et al. Interpretation and management of INR results: a case history based survey in 13 countries. Thromb Res. 2012;130:309–315.
   PubMed Web of Science ®Google Scholar
• Kristoffersen AH, Thue G, Sandberg S. Postanalytical external quality assessment of warfarin monitoring in primary healthcare. Clin Chem. 2006;52:1871–1878.
   PubMed Web of Science ®Google Scholar
• Rose AJ. Improving the management of warfarin may be easier than we think. Circulation. 2012;126:2277–2279.
   PubMed Web of Science ®Google Scholar
• Stewart A, Ganguli A, FitzGerald R, et al. Variation in warfarin prescribing and dosing in the UK: a national survey of anticoagulation clinics. J Clin Pharm Ther. 2015;40:466–471.
   PubMed Web of Science ®Google Scholar
• Van Spall HG, Wallentin L, Yusuf S, et al. Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial. Circulation. 2012;126:2309–2316.
   PubMed Web of Science ®Google Scholar
• Rose AJ, Hylek EM, Berlowitz DR, et al. Prompt repeat testing after out-of-range INR values: a quality indicator for anticoagulation care. Circ Cardiovasc Qual Outcomes. 2011;4:276–282.
   PubMed Web of Science ®Google Scholar
• Bauersachs RM. Use of anticoagulants in elderly patients. Thromb Res. 2012;129:107–115.
   PubMed Web of Science ®Google Scholar
• Shah RU, Rupp AB, Mowery D, et al. Changes in oral anticoagulant treatment rates in atrial fibrillation before and after the introduction of direct oral anticoagulants. Neuroepidemiology. 2016;47:201–209.
   PubMed Web of Science ®Google Scholar
• Brown JD, Shewale AR, Dherange P, et al. A comparison of oral anticoagulant use for atrial fibrillation in the pre- and post-DOAC eras. Drugs Aging. 2016;33:427–436.
   PubMed Web of Science ®Google Scholar
• Norwegian Prescription Database TNIoPHN, Norwegian Prescription Database, The Norwegian Institute of Public Health (NIPH); [Internet]. 2017. Available from: http://www.norpd.no/
   Google Scholar
• Rose AJ, Ozonoff A, Berlowitz DR, et al. Warfarin dose management affects INR control. J Thromb Haemost. 2009;7:94–101.
   PubMed Web of Science ®Google Scholar
• Orkaby AR, Ozonoff A, Reisman JI, et al. Continued use of warfarin in veterans with atrial fibrillation after dementia diagnosis. J Am Geriatr Soc. 2017;65:249–256.
   PubMed Web of Science ®Google Scholar
• Stollberger C, Brooks R, Finsterer J, et al. Use of direct-acting oral anticoagulants in nonagenarians: a call for more data. Drugs Aging. 2016;33:315–320.
   PubMed Web of Science ®Google Scholar
• Statens Legemiddelverk Interaksjonssøk (The Norwegian Medicines Agency, Medicines Interactions Database); [Internet]. 2015. Available from: https://www.legemiddelsok.no/sider/Interaksjoner.aspx
   Google Scholar
• Reikvam A, Sandset PM. Guidelines for warfarin treatment in clinical practice. Oslo, Norway: The Norwegian Medical Association; 2005.
   Google Scholar
• Interaksjonsdatabase for norske klinikere (Drug interaction database for Norwegian clinicians); [Internet]. 2012. Available from: http://interaksjoner.azurewebsites.net/
   Google Scholar
• Interaksjonsanalyse i Felleskatalogen (Interaction analysis in Felleskatalogen); [Internet]. 2015. Available from: http://www.felleskatalogen.no/medisin/interaksjon.
   Google Scholar
• Ahmed A, Stephens JC, Kaus CA, et al. Impact of preemptive warfarin dose reduction on anticoagulation after initiation of trimethoprim-sulfamethoxazole or levofloxacin. J Thromb Thrombolysis. 2008;26:44–48.
   PubMed Web of Science ®Google Scholar
• Baglin T. Avoiding overanticoagulation: knowing your antibiotics. Thromb Haemost. 2002;88:703–704.
   PubMed Web of Science ®Google Scholar
• Glasheen JJ, Fugit RV, Prochazka AV. The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens. J Gen Intern Med. 2005;20:653–656.
   PubMed Web of Science ®Google Scholar
• Hassall C, Feetam CL, Leach RH, et al. Letter: potentiation of warfarin by co-trimoxazole. Lancet. 1975;2:1155–1156.
   PubMed Web of Science ®Google Scholar
• Visser LE, Penning-van Bees FJ, Kasbergen AA, et al. Overanticoagulation associated with combined use of antibacterial drugs and acenocoumarol or phenprocoumon anticoagulants. Thromb Haemost. 2002;88:705–710.
   PubMed Web of Science ®Google Scholar
• Banet GA, Waterman AD, Milligan PE, et al. Warfarin dose reduction vs watchful waiting for mild elevations in the international normalized ratio. Chest. 2003;123:499–503.
   PubMed Web of Science ®Google Scholar
• Thue G, Sandberg S, Fugelli P. The erythrocyte sedimentation rate in general practice: clinical assessment based on case histories. Scand J Clin Lab Invest. 1994;54:291–300.
   PubMed Web of Science ®Google Scholar
• Skeie S, Perich C, Ricos C, et al. Postanalytical external quality assessment of blood glucose and hemoglobin A1c: an international survey. Clin Chem. 2005;51:1145–1153.
   PubMed Web of Science ®Google Scholar
• Skeie S, Thue G, Sandberg S. Use and interpretation of HbA1c testing in general practice. Implications for quality of care. Scand J Clin Lab Invest. 2000;60:349–356.
   PubMed Web of Science ®Google Scholar
• Mannheimer B, Andersson ML, Jarnbert-Pettersson H, et al. The effect of carbamazepine on warfarin anticoagulation: a register-based nationwide cohort study involving the Swedish population. J Thromb Haemost. 2016;14:765–771.
   PubMed Web of Science ®Google Scholar
• Sequist TD, Gandhi TK, Karson AS, et al. A randomized trial of electronic clinical reminders to improve quality of care for diabetes and coronary artery disease. J Am Med Inform Assoc. 2005;12:431–437.
   PubMed Web of Science ®Google Scholar
• Strom BL, Schinnar R, Aberra F, et al. Unintended effects of a computerized physician order entry nearly hard-stop alert to prevent a drug interaction: a randomized controlled trial. Arch Intern Med. 2010;170:1578–1583.
   PubMed Web of Science ®Google Scholar
• Brosstad F. Arteriell og venøs tromboembolisme: profylakse og behandling (Arterial and venous thromboembolism: prophylaxis and treatment). Oslo, Norway: Rikshospitalet; 2010.
   Google Scholar
• Schulman S, Melinyshyn A, Ennis D, et al. Single-dose adjustment versus no adjustment of warfarin in stably anticoagulated patients with an occasional international normalized ratio (INR) out of range. Thromb Res. 2010;125:393–397.
   PubMed Web of Science ®Google Scholar
• Nasjonale faglige retningslinjer for antibiotikabruk i primaerhelsetjenesten (National guidelines for treatment with antibiotics in the primary health care). Oslo: Helsedirektoratet (The Norwegian Directorate of Health), 2015. Available from: http://www.antibiotikaiallmennpraksis.no/
   Google Scholar
• Fischer HD, Juurlink DN, Mamdani MM, et al. Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents: a population-based study. Arch Intern Med. 2010;170:617–621.
   PubMedGoogle Scholar
• Lane MA, Zeringue A, McDonald JR. Serious bleeding events due to warfarin and antibiotic co-prescription in a cohort of veterans. Am J Med. 2014;127:657–663.
   PubMed Web of Science ®Google Scholar
• Ageno W, Gallus AS, Wittkowsky A, et al. Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e44S–e88S.
   PubMed Web of Science ®Google Scholar
• Schalekamp T, van Geest-Daalderop JH, Kramer MH, et al. Coumarin anticoagulants and co-trimoxazole: avoid the combination rather than manage the interaction. Eur J Clin Pharmacol. 2007;63:335–343.
   PubMed Web of Science ®Google Scholar
• Keeling D, Baglin T, Tait C, et al. Guidelines on oral anticoagulation with warfarin – fourth edition. Br J Haematol. 2011;154:311–324.
   PubMed Web of Science ®Google Scholar
• Bungard TJ, Yakiwchuk E, Foisy M, et al. Drug interactions involving warfarin: practice tool and practical management tips. Can Pharm J/Revue Des Pharmaciens Du Canada. 2011;144:21–25.
   Google Scholar
• Bungard TJ, Gardner L, Archer SL, et al. Evaluation of a pharmacist-managed anticoagulation clinic: improving patient care. Open Med. 2009;3:e16–e21.
   PubMedGoogle Scholar
• Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet. 2003;362:1225–1230.
   PubMed Web of Science ®Google Scholar
• Pearson SA, Moxey A, Robertson J, et al. Do computerised clinical decision support systems for prescribing change practice? A systematic review of the literature (1990–2007). BMC Health Serv Res. 2009;9:154.
   PubMed Web of Science ®Google Scholar